Answer:
Daily measurement of credit analyst production.
Explanation:
The financial institutions have a department that is in charge of deciding if a credit application is viable or not. Usually there is a great amount of credit applicants and the work load is high for the credit analyst that have to give a financial assessment of each customer asking for a loan.
In this context the measurement of the time that is spend by each credit analyst in order to successfully complete the analysis of one application is vital in order to decide what is going to be the number of credits that each analyst must process in a day.
Usually the Manager of this department measures the time spend by an analyst regarding the type of loan that the client is asking for. In this sense it will be faster to analyze an application that only ask for a credit card than an application that ask for a mortgage.
Upon the results they divide the quantity of hours available to work into the time spend to each analysis and finally decide what is going to be the final amount of credits that an analyst most process.
I believe that the results of this measurements are optimal if the sample that is used is broad and it takes into account days where the number of credits available to analyze are few and a lot.
Answer: Option A
Explanation: In wimples words, a summary report refers to the statement that is prepared by the organisation with the sole objective of helping the executive level managers in their decision making.
Such reports go through various phases and is converted from a detailed explanation to the points that are most relevant to the organisation. It provides a short form detail of the factors that needs most attention of top managers.
As the top managers have to attend a number of sues they will be unable to make any step from detailed information as that will be time consuming for them.
Answer:
No Change is expected on Stock value.
Explanation:
From the statement, it is evident that the EPS of $ 5 has been arrived at after factoring in the news about the FDA approval of the drug. This mere announcement was enough to raise the value of the company's EPS. For this reason, when the company releases its next earnings report, the price of the company's stock will not be change. This is because the news about FDA's approval of the drug was already absorbed.